Which antihypertensive medications are safe to use during adrenal vein sampling?

Blood Pressure Medications Safe During Adrenal Vein Sampling

Alpha-blockers (doxazosin, prazosin, terazosin), calcium channel blockers (diltiazem, verapamil, nifedipine), and vasodilators (hydralazine) are safe to use during adrenal vein sampling and should be the primary antihypertensive agents during the procedure. 1, 2

Medications to Use During AVS

The following antihypertensives do not interfere with aldosterone-to-renin ratio interpretation and can be safely continued:

• Alpha-blockers: Doxazosin, prazosin, terazosin 1, 2
• Calcium channel blockers:
  • Long-acting formulations: Diltiazem, verapamil, nifedipine 1, 2
  • Both dihydropyridine and non-dihydropyridine types are acceptable 3
• Direct vasodilators: Hydralazine 1, 2

Medications to Withdraw Before AVS

Standard Withdrawal Protocol (4-6 weeks before AVS):

• Mineralocorticoid receptor antagonists (spironolactone, eplerenone) - must be stopped 4-6 weeks prior 1, 2
• Potassium-sparing diuretics (amiloride) 2
• Potassium-wasting diuretics (thiazides, loop diuretics) 2

Medications to Withdraw 2 Weeks Before AVS (if BP control permits):

• Beta-blockers - suppress renin secretion 2, 4
• ACE inhibitors - stimulate renin 2
• Angiotensin receptor blockers (ARBs) - stimulate renin 2
• Direct renin inhibitors 2
• Centrally acting agents (clonidine, alpha-methyldopa) - can be used if other options fail, but may cause false positives 3, 2

Critical Caveats for High-Risk Patients

For patients with severe hypertension or severe hypokalemia where medication withdrawal is dangerous, recent evidence suggests two important exceptions:

1. Mineralocorticoid receptor antagonists may be continued if plasma renin activity remains suppressed (PRA <0.6 ng/mL/h or direct renin concentration <25 mIU/L) 1, 5, 6. Studies show that when renin remains suppressed despite MRA therapy, AVS lateralization remains accurate with biochemical cure rates of 89% post-adrenalectomy 5, 6.

2. A shortened 2-week withdrawal protocol for renin-stimulating drugs (instead of 4-6 weeks) achieves adequate renin suppression in 94% of patients, provided renin suppression is confirmed immediately before AVS 7.

Practical Algorithm for AVS Preparation

Step 1: Switch patient to safe medications (alpha-blockers, CCBs, hydralazine) at least 4-6 weeks before AVS

Step 2: Discontinue MRAs, potassium-sparing/wasting diuretics 4-6 weeks before AVS

Step 3: If BP control permits, discontinue beta-blockers, ACE inhibitors, ARBs 2 weeks before AVS

Step 4: If patient cannot tolerate withdrawal due to severe hypertension/hypokalemia:

• Consider continuing MRA if renin remains suppressed
• Measure plasma renin activity immediately before AVS to confirm suppression
• Proceed only if PRA <0.6 ng/mL/h or DRC <25 mIU/L 1

Step 5: Correct hypokalemia and ensure liberal sodium intake before procedure 2

Additional Considerations

• Perform AVS in the morning after patient has been upright for at least 2 hours, then seated for 5-15 minutes before sampling 2
• Oral contraceptives in women may cause false-positive results with direct renin concentration; consider measuring plasma renin activity instead or discontinue for 1 month 2
• High dietary sodium intake suppresses renin, while sodium restriction increases it - patients should follow a liberal sodium diet 1, 2

The evidence strongly supports that proper medication management is critical for accurate AVS interpretation, but in severe cases where withdrawal risks outweigh benefits, continuation of certain medications (particularly MRAs) with confirmed renin suppression provides a safe alternative 5, 6, 8.